Stock PHXM PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus PHAXIAM Therapeutics S.A. Euronext Paris

Equities

PHXM

FR0011471135

Real-time Euronext Paris
Other stock markets
 04:45:11 2024-05-02 am EDT 		5-day change 1st Jan Change
2.905 EUR -1.86% Intraday chart for PHAXIAM Therapeutics S.A. -0.34% -36.85%
Apr. 15 Phaxiam initiates trial in infective endocarditis CF
Apr. 15 PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus CI

Evolution of the average Target Price on PHAXIAM Therapeutics S.A.

Price target over the last 5 years

History of analyst recommendation changes

5f3b.A-dTwAexXGU46yzB-TmukDkDLeGKtdz1D9dhzRtz4lU.TqkRuU_EFw1orEiOi1qdoUxVaqjl-Y-2eJgP4F8wzzhggWW4RYcbIVfYGA~30a87ffc364d8c06fb529423f3a6ee8f

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.96 EUR
Average target price
6.85 EUR
Spread / Average Target
+131.42%
High Price Target
8 EUR
Spread / Highest target
+170.27%
Low Price Target
5.7 EUR
Spread / Lowest Target
+92.57%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. PHXM Stock
  5. Consensus PHAXIAM Therapeutics S.A.